LINC00942

Across TCGA pan-cancer cohorts, LINC00942 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of LINC00942’s most consistent transcriptional readouts.

The strongest signal is observed in lung adenocarcinoma (LUAD), where LINC00942 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC00942 is over-expressed in tumor, although a few such as BRCA and PRAD show the opposite, repressed pattern.

LUAD, THCA, and HNSC are the cancer types where LINC00942 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC00942 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LUAD	All	All	+0.909	<.001	8	view →
THCA	Female	All	+0.396	<.001	8	view →
HNSC	All	II,III,IV	+0.964	<.001	7	view →
KIRC	All	II,III,IV	+0.530	.005	7	view →
KIRP	All	II,III,IV	+1.836	.006	6	view →
LUSC	All	All	+1.054	<.001	4	view →
UCEC	All	All	+0.679	.027	4	view →
BRCA	All	All	−0.181	.002	4	view →
LIHC	All	All	+0.728	.003	2	view →
PRAD	All	All	−0.271	<.001	2	view →
COAD	All	All	+0.193	.034	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

LINC00942–LUAD

Open the LUAD breakdown →